SCHEMBL4262937

SCHEMBL4262937

NC(Cc1c[nH]c2cc(F)ccc12)C(=O)O.NC(Cc1c[nH]c2ccc(Br)cc12)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.60
KMT2A Q03164 3/20 0.60
TSHR P16473 3/20 0.60
SLC6A4 P31645 3/20 0.60
KDM4E B2RXH2 2/20 0.60
LMNA P02545 2/20 0.60
MAPT P10636 2/20 0.60
BLM P54132 2/20 0.60
PMP22 Q01453 2/20 0.60
HTR2C P28335 2/20 0.60
HTR1A P08908 2/20 0.60
ALDH1A1 P00352 1/20 0.60
CYP3A4 P08684 1/20 0.60
ADORA3 P0DMS8 1/20 0.60
ALOX15 P16050 1/20 0.60
NFKB1 P19838 1/20 0.60
HTR7 P34969 1/20 0.60
HTR2B P41595 1/20 0.60
MTOR P42345 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4262934 1.00 HTR2A (0.60) HTR2AKMT2ATSHRSLC6A4KDM4E
SCHEMBL30405928 0.89 KMT2A (0.73) HTR2AKMT2ATSHRSLC6A4KDM4E
SCHEMBL19871231 0.89 KMT2A (0.73) HTR2AKMT2ATSHRSLC6A4KDM4E
SCHEMBL307776 0.89 KMT2A (0.73) HTR2AKMT2ATSHRSLC6A4KDM4E
SCHEMBL454983 0.89 KMT2A (0.73) HTR2AKMT2ATSHRSLC6A4KDM4E
SCHEMBL5493779 0.89 KMT2A (0.73) HTR2AKMT2ATSHRSLC6A4KDM4E
SCHEMBL29382361 0.89 KMT2A (0.73) HTR2AKMT2ATSHRSLC6A4KDM4E
SCHEMBL248870 0.89 KMT2A (0.66) HTR2AKMT2ATSHRSLC6A4KDM4E
SCHEMBL2330930 0.89 KMT2A (0.66) HTR2AKMT2ATSHRSLC6A4KDM4E
SCHEMBL30381733 0.89 KMT2A (0.66) HTR2AKMT2ATSHRSLC6A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023139-A1 Method For Site-Specifically Introducing Non-Natural Amino Acid Into Protien Using Mitochondrial Protein and Method For Effectively Preparing Trna GIFU UNIVERSITY (JP) 2009-01-22 US disclosed
EP-1818400-A1 METHOD OF SITE-SPECIFICALLY INTRODUCING NON-NATURAL AMINO ACID INTO PROTEIN USING MITOCHONDRIAL PROTEIN AND METHOD FOR EFFECTIVELY PREPARING tRNA Gifu University (JP) 2007-08-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023139-A1 Method For Site-Specifically Introducing Non-Natural Amino Acid Into Protien Using Mitochondrial Protein and Method For Effectively Preparing Trna FARS2, MARS2, AARS1 HTR2A 702/4885KMT2A 1779/4885TSHR 1649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.